Inventor · disambiguated record
Grant Gallagher
Also filed as: GALLAGHER GRANT · GALLAGHER GRANT E
23 granted patents·3 pending applications·78 citations·filing 2008–2021
92Inventor score
Files withGALLAGHER GRANT16MEDICAL DIAGNOSTIC LAB LLC4MEDICAL DIAGNOSTIC LABORATORIES LLC3VENENUM BIODESIGN LLC2MEDICAL DIAGNOSITCS LABORATORIES LLC1
Top patents by PatentIndex Score
26 records- 0195US8946150B2Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofGALLAGHER GRANT·Filed 2012·Granted Feb 3, 2015·34 cites·17 claims
- 0294US9169292B2Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofGALLAGHER GRANT·Filed 2013·Granted Oct 27, 2015·34 cites·5 claims
- 0386US9605027B2Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofGALLAGHER GRANT·Filed 2015·Granted Mar 28, 2017·6 cites·13 claims
- 0475US8282964B2Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambdaGALLAGHER GRANT·Filed 2009·Granted Oct 9, 2012·3 cites·18 claims
- 0574US9868776B2Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseasesGALLAGHER GRANT·Filed 2015·Granted Jan 16, 2018·1 cites·9 claims
- 0669US8206925B2Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseasesGALLAGHER GRANT·Filed 2009·Granted Jun 26, 2012·0 cites·5 claims
- 0766US11883420B2Sting agonists for treating bladder cancer and solid tumorsVENENUM BIODESIGN LLC·Filed 2021·Granted Jan 30, 2024·0 cites·4 claims
- 0865US9464321B2Methods and reagents that specifically detect, distinguish and quantify IFN-λ2 mRNA from IFN-λ3 mRNA in humansGALLAGHER GRANT·Filed 2014·Granted Oct 11, 2016·0 cites·12 claims
- 0964US9506066B2Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activityMEDICAL DIAGNOSTIC LABORATORIES LLC·Filed 2014·Granted Nov 29, 2016·0 cites·12 claims
- 1064US9187750B2Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseasesGALLAGHER GRANT·Filed 2013·Granted Nov 17, 2015·0 cites·12 claims
- 1163US11110106B2Sting agonists for treating bladder cancer and solid tumorsVENENUM BIODESIGN LLC·Filed 2020·Granted Sep 7, 2021·0 cites·20 claims
- 1262US10416172B2Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signalingGALLAGHER GRANT·Filed 2011·Granted Sep 17, 2019·0 cites·14 claims
- 1360US9163238B2Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activityMEDICAL DIAGNOSTIC LAB LLC·Filed 2014·Granted Oct 20, 2015·0 cites·5 claims
- 1460US2017038396A1ELISA for a Naturally-Occurring Soluble Truncated Form of IL-23 ReceptorMEDICAL DIAGNOSTIC LABORATORIES LLC·Filed 2016·Application pending·0 cites
- 1559US10144974B2Methods and reagents that specifically detect, distinguish and quantify IFN-LAMBDA2 mRNA from IFN-LAMBDA3 mRNA in humansGALLAGHER GRANT·Filed 2016·Granted Dec 4, 2018·0 cites·3 claims
- 1659US2013196333A1SPLICE VARIANTS OF HUMAN IL-23 RECEPTOR (IL-23R) mRNA AND USE OF A DELTA 9 ISOFORM IN PREDICTING INFLAMMATORY BOWEL DISEASESGALLAGHER GRANT·Filed 2013·Application pending·0 cites
- 1758US2013183755A1Therapeutic application of isolated naturally-occurring soluble truncated forms of il-23 receptorGALLAGHER GRANT·Filed 2013·Application pending·0 cites
- 1857US8802648B2Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activityMEDICAL DIAGNOSTIC LAB LLC·Filed 2012·Granted Aug 12, 2014·0 cites·9 claims
- 1957US8618070B2Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseasesGALLAGHER GRANT·Filed 2011·Granted Dec 31, 2013·0 cites·4 claims
- 2055US9850489B2Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activityMEDICAL DIAGNOSITCS LABORATORIES LLC·Filed 2016·Granted Dec 26, 2017·0 cites·6 claims
- 2155US9523073B2Elisa for a naturally-occurring soluble truncated form of IL-23 receptorGALLAGHER GRANT·Filed 2011·Granted Dec 20, 2016·0 cites·12 claims
- 2255US8354125B2Ex-vivo treatment of peripheral blood leukocytes with IFN-λGALLAGHER GRANT·Filed 2008·Granted Jan 15, 2013·0 cites·14 claims
- 2354US8933049B2Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activityMEDICAL DIAGNOSTIC LAB LLC·Filed 2013·Granted Jan 13, 2015·0 cites·7 claims
- 2454US8349808B2Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activityMEDICAL DIAGNOSTIC LAB LLC·Filed 2010·Granted Jan 8, 2013·0 cites·9 claims
- 2551USRE49026EPolypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofMEDICAL DIAGNOSTIC LABORATORIES LLC·Filed 2017·Granted Apr 12, 2022·0 cites·36 claims
- 2646US8771666B2Ex-vivo treatment of T-cells with IFN-λGALLAGHER GRANT·Filed 2012·Granted Jul 8, 2014·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Grant Gallagher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →